Report #2874696

Overview

Sex

Unknown

Age

Age unknown

State

PA

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Vaccine stored outside recommended conditions and administered to patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received Flu Seasonal TIV Quebec (FluLaval 2025-2026 season) for prophylaxis. Co-suspect products included DTPa-IPV (Kinrix) for prophylaxis, Herpes zoster (Shingrix) for prophylaxis and HAB (Twinrix) for prophylaxis. On an unknown date, the patient received FluLaval 2025-2026 season, Kinrix, Shingrix and Twinrix. On an unknown date, an unknown time after receiving FluLaval 2025-2026 season, Kinrix, Shingrix and Twinrix, the patient experienced incorrect storage of drug (Verbatim: Vaccine stored outside recommended conditions and administered to patient). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 19-NOV-2025 It was reported the vaccines were kept at Temperature negative1.65 degree Celsius for 3 hours. After collecting the temperature excursion information. Medical assistant inquired recommendations in case the vaccines were administered. She stated that she was making a general consult and she did not confirm that a patient had been administered with any of these vaccines however she approved the follow-up from Safety. The reporter asked the recommendation if someone was administered the vaccine, or do they need to be revaccinated, The reporter consented to follow up.